Global Antihormonal Cancer Therapies Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors.
LPI (LP Information)' newest research report, the “Antihormonal Cancer Therapies Industry Forecast” looks at past sales and reviews total world Antihormonal Cancer Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Antihormonal Cancer Therapies sales for 2023 through 2029. With Antihormonal Cancer Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antihormonal Cancer Therapies industry.
This Insight Report provides a comprehensive analysis of the global Antihormonal Cancer Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antihormonal Cancer Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antihormonal Cancer Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antihormonal Cancer Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antihormonal Cancer Therapies.
The global Antihormonal Cancer Therapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antihormonal Cancer Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antihormonal Cancer Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antihormonal Cancer Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antihormonal Cancer Therapies players cover AstraZeneca, Novartis, Pfizer, Sanofi, Takeda, Roche, Amgen, Samyang Biopharmaceuticals and Tolmar, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antihormonal Cancer Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors.
LPI (LP Information)' newest research report, the “Antihormonal Cancer Therapies Industry Forecast” looks at past sales and reviews total world Antihormonal Cancer Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Antihormonal Cancer Therapies sales for 2023 through 2029. With Antihormonal Cancer Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antihormonal Cancer Therapies industry.
This Insight Report provides a comprehensive analysis of the global Antihormonal Cancer Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antihormonal Cancer Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antihormonal Cancer Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antihormonal Cancer Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antihormonal Cancer Therapies.
The global Antihormonal Cancer Therapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antihormonal Cancer Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antihormonal Cancer Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antihormonal Cancer Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antihormonal Cancer Therapies players cover AstraZeneca, Novartis, Pfizer, Sanofi, Takeda, Roche, Amgen, Samyang Biopharmaceuticals and Tolmar, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antihormonal Cancer Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Radiations
- Drugs
- Surgeries
- Others
- Breast Cancer
- Prostate Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Novartis
- Pfizer
- Sanofi
- Takeda
- Roche
- Amgen
- Samyang Biopharmaceuticals
- Tolmar
- Bluebird Bio
- Bristol-Myers Squibb
- Exelixis
- Guardant Health
- Illumina
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antihormonal Cancer Therapies Market Size 2018-2029
2.1.2 Antihormonal Cancer Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Antihormonal Cancer Therapies Segment by Type
2.2.1 Radiations
2.2.2 Drugs
2.2.3 Surgeries
2.2.4 Others
2.3 Antihormonal Cancer Therapies Market Size by Type
2.3.1 Antihormonal Cancer Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
2.4 Antihormonal Cancer Therapies Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Other
2.5 Antihormonal Cancer Therapies Market Size by Application
2.5.1 Antihormonal Cancer Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
3 ANTIHORMONAL CANCER THERAPIES MARKET SIZE BY PLAYER
3.1 Antihormonal Cancer Therapies Market Size Market Share by Players
3.1.1 Global Antihormonal Cancer Therapies Revenue by Players (2018-2023)
3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Antihormonal Cancer Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIHORMONAL CANCER THERAPIES BY REGIONS
4.1 Antihormonal Cancer Therapies Market Size by Regions (2018-2023)
4.2 Americas Antihormonal Cancer Therapies Market Size Growth (2018-2023)
4.3 APAC Antihormonal Cancer Therapies Market Size Growth (2018-2023)
4.4 Europe Antihormonal Cancer Therapies Market Size Growth (2018-2023)
4.5 Middle East & Africa Antihormonal Cancer Therapies Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Antihormonal Cancer Therapies Market Size by Country (2018-2023)
5.2 Americas Antihormonal Cancer Therapies Market Size by Type (2018-2023)
5.3 Americas Antihormonal Cancer Therapies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antihormonal Cancer Therapies Market Size by Region (2018-2023)
6.2 APAC Antihormonal Cancer Therapies Market Size by Type (2018-2023)
6.3 APAC Antihormonal Cancer Therapies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antihormonal Cancer Therapies by Country (2018-2023)
7.2 Europe Antihormonal Cancer Therapies Market Size by Type (2018-2023)
7.3 Europe Antihormonal Cancer Therapies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antihormonal Cancer Therapies by Region (2018-2023)
8.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2018-2023)
8.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIHORMONAL CANCER THERAPIES MARKET FORECAST
10.1 Global Antihormonal Cancer Therapies Forecast by Regions (2024-2029)
10.1.1 Global Antihormonal Cancer Therapies Forecast by Regions (2024-2029)
10.1.2 Americas Antihormonal Cancer Therapies Forecast
10.1.3 APAC Antihormonal Cancer Therapies Forecast
10.1.4 Europe Antihormonal Cancer Therapies Forecast
10.1.5 Middle East & Africa Antihormonal Cancer Therapies Forecast
10.2 Americas Antihormonal Cancer Therapies Forecast by Country (2024-2029)
10.2.1 United States Antihormonal Cancer Therapies Market Forecast
10.2.2 Canada Antihormonal Cancer Therapies Market Forecast
10.2.3 Mexico Antihormonal Cancer Therapies Market Forecast
10.2.4 Brazil Antihormonal Cancer Therapies Market Forecast
10.3 APAC Antihormonal Cancer Therapies Forecast by Region (2024-2029)
10.3.1 China Antihormonal Cancer Therapies Market Forecast
10.3.2 Japan Antihormonal Cancer Therapies Market Forecast
10.3.3 Korea Antihormonal Cancer Therapies Market Forecast
10.3.4 Southeast Asia Antihormonal Cancer Therapies Market Forecast
10.3.5 India Antihormonal Cancer Therapies Market Forecast
10.3.6 Australia Antihormonal Cancer Therapies Market Forecast
10.4 Europe Antihormonal Cancer Therapies Forecast by Country (2024-2029)
10.4.1 Germany Antihormonal Cancer Therapies Market Forecast
10.4.2 France Antihormonal Cancer Therapies Market Forecast
10.4.3 UK Antihormonal Cancer Therapies Market Forecast
10.4.4 Italy Antihormonal Cancer Therapies Market Forecast
10.4.5 Russia Antihormonal Cancer Therapies Market Forecast
10.5 Middle East & Africa Antihormonal Cancer Therapies Forecast by Region (2024-2029)
10.5.1 Egypt Antihormonal Cancer Therapies Market Forecast
10.5.2 South Africa Antihormonal Cancer Therapies Market Forecast
10.5.3 Israel Antihormonal Cancer Therapies Market Forecast
10.5.4 Turkey Antihormonal Cancer Therapies Market Forecast
10.5.5 GCC Countries Antihormonal Cancer Therapies Market Forecast
10.6 Global Antihormonal Cancer Therapies Forecast by Type (2024-2029)
10.7 Global Antihormonal Cancer Therapies Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Antihormonal Cancer Therapies Product Offered
11.1.3 AstraZeneca Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Antihormonal Cancer Therapies Product Offered
11.2.3 Novartis Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Antihormonal Cancer Therapies Product Offered
11.3.3 Pfizer Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Antihormonal Cancer Therapies Product Offered
11.4.3 Sanofi Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Antihormonal Cancer Therapies Product Offered
11.5.3 Takeda Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Antihormonal Cancer Therapies Product Offered
11.6.3 Roche Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Antihormonal Cancer Therapies Product Offered
11.7.3 Amgen Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Samyang Biopharmaceuticals
11.8.1 Samyang Biopharmaceuticals Company Information
11.8.2 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Offered
11.8.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Samyang Biopharmaceuticals Main Business Overview
11.8.5 Samyang Biopharmaceuticals Latest Developments
11.9 Tolmar
11.9.1 Tolmar Company Information
11.9.2 Tolmar Antihormonal Cancer Therapies Product Offered
11.9.3 Tolmar Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Tolmar Main Business Overview
11.9.5 Tolmar Latest Developments
11.10 Bluebird Bio
11.10.1 Bluebird Bio Company Information
11.10.2 Bluebird Bio Antihormonal Cancer Therapies Product Offered
11.10.3 Bluebird Bio Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Bluebird Bio Main Business Overview
11.10.5 Bluebird Bio Latest Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Information
11.11.2 Bristol-Myers Squibb Antihormonal Cancer Therapies Product Offered
11.11.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bristol-Myers Squibb Main Business Overview
11.11.5 Bristol-Myers Squibb Latest Developments
11.12 Exelixis
11.12.1 Exelixis Company Information
11.12.2 Exelixis Antihormonal Cancer Therapies Product Offered
11.12.3 Exelixis Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Exelixis Main Business Overview
11.12.5 Exelixis Latest Developments
11.13 Guardant Health
11.13.1 Guardant Health Company Information
11.13.2 Guardant Health Antihormonal Cancer Therapies Product Offered
11.13.3 Guardant Health Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Guardant Health Main Business Overview
11.13.5 Guardant Health Latest Developments
11.14 Illumina
11.14.1 Illumina Company Information
11.14.2 Illumina Antihormonal Cancer Therapies Product Offered
11.14.3 Illumina Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Illumina Main Business Overview
11.14.5 Illumina Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antihormonal Cancer Therapies Market Size 2018-2029
2.1.2 Antihormonal Cancer Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Antihormonal Cancer Therapies Segment by Type
2.2.1 Radiations
2.2.2 Drugs
2.2.3 Surgeries
2.2.4 Others
2.3 Antihormonal Cancer Therapies Market Size by Type
2.3.1 Antihormonal Cancer Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
2.4 Antihormonal Cancer Therapies Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Other
2.5 Antihormonal Cancer Therapies Market Size by Application
2.5.1 Antihormonal Cancer Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
3 ANTIHORMONAL CANCER THERAPIES MARKET SIZE BY PLAYER
3.1 Antihormonal Cancer Therapies Market Size Market Share by Players
3.1.1 Global Antihormonal Cancer Therapies Revenue by Players (2018-2023)
3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Antihormonal Cancer Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIHORMONAL CANCER THERAPIES BY REGIONS
4.1 Antihormonal Cancer Therapies Market Size by Regions (2018-2023)
4.2 Americas Antihormonal Cancer Therapies Market Size Growth (2018-2023)
4.3 APAC Antihormonal Cancer Therapies Market Size Growth (2018-2023)
4.4 Europe Antihormonal Cancer Therapies Market Size Growth (2018-2023)
4.5 Middle East & Africa Antihormonal Cancer Therapies Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Antihormonal Cancer Therapies Market Size by Country (2018-2023)
5.2 Americas Antihormonal Cancer Therapies Market Size by Type (2018-2023)
5.3 Americas Antihormonal Cancer Therapies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antihormonal Cancer Therapies Market Size by Region (2018-2023)
6.2 APAC Antihormonal Cancer Therapies Market Size by Type (2018-2023)
6.3 APAC Antihormonal Cancer Therapies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antihormonal Cancer Therapies by Country (2018-2023)
7.2 Europe Antihormonal Cancer Therapies Market Size by Type (2018-2023)
7.3 Europe Antihormonal Cancer Therapies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antihormonal Cancer Therapies by Region (2018-2023)
8.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2018-2023)
8.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIHORMONAL CANCER THERAPIES MARKET FORECAST
10.1 Global Antihormonal Cancer Therapies Forecast by Regions (2024-2029)
10.1.1 Global Antihormonal Cancer Therapies Forecast by Regions (2024-2029)
10.1.2 Americas Antihormonal Cancer Therapies Forecast
10.1.3 APAC Antihormonal Cancer Therapies Forecast
10.1.4 Europe Antihormonal Cancer Therapies Forecast
10.1.5 Middle East & Africa Antihormonal Cancer Therapies Forecast
10.2 Americas Antihormonal Cancer Therapies Forecast by Country (2024-2029)
10.2.1 United States Antihormonal Cancer Therapies Market Forecast
10.2.2 Canada Antihormonal Cancer Therapies Market Forecast
10.2.3 Mexico Antihormonal Cancer Therapies Market Forecast
10.2.4 Brazil Antihormonal Cancer Therapies Market Forecast
10.3 APAC Antihormonal Cancer Therapies Forecast by Region (2024-2029)
10.3.1 China Antihormonal Cancer Therapies Market Forecast
10.3.2 Japan Antihormonal Cancer Therapies Market Forecast
10.3.3 Korea Antihormonal Cancer Therapies Market Forecast
10.3.4 Southeast Asia Antihormonal Cancer Therapies Market Forecast
10.3.5 India Antihormonal Cancer Therapies Market Forecast
10.3.6 Australia Antihormonal Cancer Therapies Market Forecast
10.4 Europe Antihormonal Cancer Therapies Forecast by Country (2024-2029)
10.4.1 Germany Antihormonal Cancer Therapies Market Forecast
10.4.2 France Antihormonal Cancer Therapies Market Forecast
10.4.3 UK Antihormonal Cancer Therapies Market Forecast
10.4.4 Italy Antihormonal Cancer Therapies Market Forecast
10.4.5 Russia Antihormonal Cancer Therapies Market Forecast
10.5 Middle East & Africa Antihormonal Cancer Therapies Forecast by Region (2024-2029)
10.5.1 Egypt Antihormonal Cancer Therapies Market Forecast
10.5.2 South Africa Antihormonal Cancer Therapies Market Forecast
10.5.3 Israel Antihormonal Cancer Therapies Market Forecast
10.5.4 Turkey Antihormonal Cancer Therapies Market Forecast
10.5.5 GCC Countries Antihormonal Cancer Therapies Market Forecast
10.6 Global Antihormonal Cancer Therapies Forecast by Type (2024-2029)
10.7 Global Antihormonal Cancer Therapies Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Antihormonal Cancer Therapies Product Offered
11.1.3 AstraZeneca Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Antihormonal Cancer Therapies Product Offered
11.2.3 Novartis Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Antihormonal Cancer Therapies Product Offered
11.3.3 Pfizer Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Antihormonal Cancer Therapies Product Offered
11.4.3 Sanofi Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Antihormonal Cancer Therapies Product Offered
11.5.3 Takeda Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Antihormonal Cancer Therapies Product Offered
11.6.3 Roche Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Antihormonal Cancer Therapies Product Offered
11.7.3 Amgen Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Samyang Biopharmaceuticals
11.8.1 Samyang Biopharmaceuticals Company Information
11.8.2 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Offered
11.8.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Samyang Biopharmaceuticals Main Business Overview
11.8.5 Samyang Biopharmaceuticals Latest Developments
11.9 Tolmar
11.9.1 Tolmar Company Information
11.9.2 Tolmar Antihormonal Cancer Therapies Product Offered
11.9.3 Tolmar Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Tolmar Main Business Overview
11.9.5 Tolmar Latest Developments
11.10 Bluebird Bio
11.10.1 Bluebird Bio Company Information
11.10.2 Bluebird Bio Antihormonal Cancer Therapies Product Offered
11.10.3 Bluebird Bio Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Bluebird Bio Main Business Overview
11.10.5 Bluebird Bio Latest Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Information
11.11.2 Bristol-Myers Squibb Antihormonal Cancer Therapies Product Offered
11.11.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bristol-Myers Squibb Main Business Overview
11.11.5 Bristol-Myers Squibb Latest Developments
11.12 Exelixis
11.12.1 Exelixis Company Information
11.12.2 Exelixis Antihormonal Cancer Therapies Product Offered
11.12.3 Exelixis Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Exelixis Main Business Overview
11.12.5 Exelixis Latest Developments
11.13 Guardant Health
11.13.1 Guardant Health Company Information
11.13.2 Guardant Health Antihormonal Cancer Therapies Product Offered
11.13.3 Guardant Health Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Guardant Health Main Business Overview
11.13.5 Guardant Health Latest Developments
11.14 Illumina
11.14.1 Illumina Company Information
11.14.2 Illumina Antihormonal Cancer Therapies Product Offered
11.14.3 Illumina Antihormonal Cancer Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Illumina Main Business Overview
11.14.5 Illumina Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antihormonal Cancer Therapies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Radiations
Table 3. Major Players of Drugs
Table 4. Major Players of Surgeries
Table 5. Major Players of Others
Table 6. Antihormonal Cancer Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 9. Antihormonal Cancer Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 12. Global Antihormonal Cancer Therapies Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Antihormonal Cancer Therapies Revenue Market Share by Player (2018-2023)
Table 14. Antihormonal Cancer Therapies Key Players Head office and Products Offered
Table 15. Antihormonal Cancer Therapies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antihormonal Cancer Therapies Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Antihormonal Cancer Therapies Market Size Market Share by Regions (2018-2023)
Table 20. Global Antihormonal Cancer Therapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Antihormonal Cancer Therapies Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Antihormonal Cancer Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Antihormonal Cancer Therapies Market Size Market Share by Country (2018-2023)
Table 24. Americas Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 26. Americas Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 28. APAC Antihormonal Cancer Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Antihormonal Cancer Therapies Market Size Market Share by Region (2018-2023)
Table 30. APAC Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 32. APAC Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 34. Europe Antihormonal Cancer Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Antihormonal Cancer Therapies Market Size Market Share by Country (2018-2023)
Table 36. Europe Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 38. Europe Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Antihormonal Cancer Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Antihormonal Cancer Therapies
Table 47. Key Market Challenges & Risks of Antihormonal Cancer Therapies
Table 48. Key Industry Trends of Antihormonal Cancer Therapies
Table 49. Global Antihormonal Cancer Therapies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Antihormonal Cancer Therapies Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Antihormonal Cancer Therapies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Antihormonal Cancer Therapies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. AstraZeneca Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 54. AstraZeneca Antihormonal Cancer Therapies Product Offered
Table 55. AstraZeneca Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Novartis Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 59. Novartis Antihormonal Cancer Therapies Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. Pfizer Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 64. Pfizer Antihormonal Cancer Therapies Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Pfizer Latest Developments
Table 68. Sanofi Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 69. Sanofi Antihormonal Cancer Therapies Product Offered
Table 70. Sanofi Main Business
Table 71. Sanofi Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Latest Developments
Table 73. Takeda Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 74. Takeda Antihormonal Cancer Therapies Product Offered
Table 75. Takeda Main Business
Table 76. Takeda Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Takeda Latest Developments
Table 78. Roche Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 79. Roche Antihormonal Cancer Therapies Product Offered
Table 80. Roche Main Business
Table 81. Roche Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Roche Latest Developments
Table 83. Amgen Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 84. Amgen Antihormonal Cancer Therapies Product Offered
Table 85. Amgen Main Business
Table 86. Amgen Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Amgen Latest Developments
Table 88. Samyang Biopharmaceuticals Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 89. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Offered
Table 90. Samyang Biopharmaceuticals Main Business
Table 91. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Samyang Biopharmaceuticals Latest Developments
Table 93. Tolmar Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 94. Tolmar Antihormonal Cancer Therapies Product Offered
Table 95. Tolmar Main Business
Table 96. Tolmar Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Tolmar Latest Developments
Table 98. Bluebird Bio Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 99. Bluebird Bio Antihormonal Cancer Therapies Product Offered
Table 100. Bluebird Bio Main Business
Table 101. Bluebird Bio Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Bluebird Bio Latest Developments
Table 103. Bristol-Myers Squibb Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 104. Bristol-Myers Squibb Antihormonal Cancer Therapies Product Offered
Table 105. Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Exelixis Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 109. Exelixis Antihormonal Cancer Therapies Product Offered
Table 110. Exelixis Main Business
Table 111. Exelixis Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Exelixis Latest Developments
Table 113. Guardant Health Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 114. Guardant Health Antihormonal Cancer Therapies Product Offered
Table 115. Guardant Health Main Business
Table 116. Guardant Health Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Guardant Health Latest Developments
Table 118. Illumina Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 119. Illumina Antihormonal Cancer Therapies Product Offered
Table 120. Illumina Main Business
Table 121. Illumina Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Illumina Latest Developments
Table 1. Antihormonal Cancer Therapies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Radiations
Table 3. Major Players of Drugs
Table 4. Major Players of Surgeries
Table 5. Major Players of Others
Table 6. Antihormonal Cancer Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 9. Antihormonal Cancer Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 12. Global Antihormonal Cancer Therapies Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Antihormonal Cancer Therapies Revenue Market Share by Player (2018-2023)
Table 14. Antihormonal Cancer Therapies Key Players Head office and Products Offered
Table 15. Antihormonal Cancer Therapies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antihormonal Cancer Therapies Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Antihormonal Cancer Therapies Market Size Market Share by Regions (2018-2023)
Table 20. Global Antihormonal Cancer Therapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Antihormonal Cancer Therapies Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Antihormonal Cancer Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Antihormonal Cancer Therapies Market Size Market Share by Country (2018-2023)
Table 24. Americas Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 26. Americas Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 28. APAC Antihormonal Cancer Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Antihormonal Cancer Therapies Market Size Market Share by Region (2018-2023)
Table 30. APAC Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 32. APAC Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 34. Europe Antihormonal Cancer Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Antihormonal Cancer Therapies Market Size Market Share by Country (2018-2023)
Table 36. Europe Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 38. Europe Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Antihormonal Cancer Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Antihormonal Cancer Therapies
Table 47. Key Market Challenges & Risks of Antihormonal Cancer Therapies
Table 48. Key Industry Trends of Antihormonal Cancer Therapies
Table 49. Global Antihormonal Cancer Therapies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Antihormonal Cancer Therapies Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Antihormonal Cancer Therapies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Antihormonal Cancer Therapies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. AstraZeneca Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 54. AstraZeneca Antihormonal Cancer Therapies Product Offered
Table 55. AstraZeneca Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Novartis Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 59. Novartis Antihormonal Cancer Therapies Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. Pfizer Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 64. Pfizer Antihormonal Cancer Therapies Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Pfizer Latest Developments
Table 68. Sanofi Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 69. Sanofi Antihormonal Cancer Therapies Product Offered
Table 70. Sanofi Main Business
Table 71. Sanofi Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Latest Developments
Table 73. Takeda Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 74. Takeda Antihormonal Cancer Therapies Product Offered
Table 75. Takeda Main Business
Table 76. Takeda Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Takeda Latest Developments
Table 78. Roche Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 79. Roche Antihormonal Cancer Therapies Product Offered
Table 80. Roche Main Business
Table 81. Roche Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Roche Latest Developments
Table 83. Amgen Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 84. Amgen Antihormonal Cancer Therapies Product Offered
Table 85. Amgen Main Business
Table 86. Amgen Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Amgen Latest Developments
Table 88. Samyang Biopharmaceuticals Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 89. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Offered
Table 90. Samyang Biopharmaceuticals Main Business
Table 91. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Samyang Biopharmaceuticals Latest Developments
Table 93. Tolmar Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 94. Tolmar Antihormonal Cancer Therapies Product Offered
Table 95. Tolmar Main Business
Table 96. Tolmar Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Tolmar Latest Developments
Table 98. Bluebird Bio Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 99. Bluebird Bio Antihormonal Cancer Therapies Product Offered
Table 100. Bluebird Bio Main Business
Table 101. Bluebird Bio Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Bluebird Bio Latest Developments
Table 103. Bristol-Myers Squibb Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 104. Bristol-Myers Squibb Antihormonal Cancer Therapies Product Offered
Table 105. Bristol-Myers Squibb Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Exelixis Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 109. Exelixis Antihormonal Cancer Therapies Product Offered
Table 110. Exelixis Main Business
Table 111. Exelixis Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Exelixis Latest Developments
Table 113. Guardant Health Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 114. Guardant Health Antihormonal Cancer Therapies Product Offered
Table 115. Guardant Health Main Business
Table 116. Guardant Health Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Guardant Health Latest Developments
Table 118. Illumina Details, Company Type, Antihormonal Cancer Therapies Area Served and Its Competitors
Table 119. Illumina Antihormonal Cancer Therapies Product Offered
Table 120. Illumina Main Business
Table 121. Illumina Antihormonal Cancer Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Illumina Latest Developments
LIST OF FIGURES
Figure 1. Antihormonal Cancer Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antihormonal Cancer Therapies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Antihormonal Cancer Therapies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Antihormonal Cancer Therapies Sales Market Share by Country/Region (2022)
Figure 8. Antihormonal Cancer Therapies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Antihormonal Cancer Therapies Market Size Market Share by Type in 2022
Figure 10. Antihormonal Cancer Therapies in Breast Cancer
Figure 11. Global Antihormonal Cancer Therapies Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. Antihormonal Cancer Therapies in Prostate Cancer
Figure 13. Global Antihormonal Cancer Therapies Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 14. Antihormonal Cancer Therapies in Other
Figure 15. Global Antihormonal Cancer Therapies Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Antihormonal Cancer Therapies Market Size Market Share by Application in 2022
Figure 17. Global Antihormonal Cancer Therapies Revenue Market Share by Player in 2022
Figure 18. Global Antihormonal Cancer Therapies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Antihormonal Cancer Therapies Value Market Share by Country in 2022
Figure 24. United States Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Antihormonal Cancer Therapies Market Size Market Share by Region in 2022
Figure 29. APAC Antihormonal Cancer Therapies Market Size Market Share by Type in 2022
Figure 30. APAC Antihormonal Cancer Therapies Market Size Market Share by Application in 2022
Figure 31. China Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Antihormonal Cancer Therapies Market Size Market Share by Country in 2022
Figure 38. Europe Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 57. United States Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 61. China Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 65. India Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 68. France Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 69. UK Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 78. Global Antihormonal Cancer Therapies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Antihormonal Cancer Therapies Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Antihormonal Cancer Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antihormonal Cancer Therapies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Antihormonal Cancer Therapies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Antihormonal Cancer Therapies Sales Market Share by Country/Region (2022)
Figure 8. Antihormonal Cancer Therapies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Antihormonal Cancer Therapies Market Size Market Share by Type in 2022
Figure 10. Antihormonal Cancer Therapies in Breast Cancer
Figure 11. Global Antihormonal Cancer Therapies Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. Antihormonal Cancer Therapies in Prostate Cancer
Figure 13. Global Antihormonal Cancer Therapies Market: Prostate Cancer (2018-2023) & ($ Millions)
Figure 14. Antihormonal Cancer Therapies in Other
Figure 15. Global Antihormonal Cancer Therapies Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Antihormonal Cancer Therapies Market Size Market Share by Application in 2022
Figure 17. Global Antihormonal Cancer Therapies Revenue Market Share by Player in 2022
Figure 18. Global Antihormonal Cancer Therapies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Antihormonal Cancer Therapies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Antihormonal Cancer Therapies Value Market Share by Country in 2022
Figure 24. United States Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Antihormonal Cancer Therapies Market Size Market Share by Region in 2022
Figure 29. APAC Antihormonal Cancer Therapies Market Size Market Share by Type in 2022
Figure 30. APAC Antihormonal Cancer Therapies Market Size Market Share by Application in 2022
Figure 31. China Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Antihormonal Cancer Therapies Market Size Market Share by Country in 2022
Figure 38. Europe Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Antihormonal Cancer Therapies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Antihormonal Cancer Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 57. United States Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 61. China Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 65. India Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 68. France Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 69. UK Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Antihormonal Cancer Therapies Market Size 2024-2029 ($ Millions)
Figure 78. Global Antihormonal Cancer Therapies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Antihormonal Cancer Therapies Market Size Market Share Forecast by Application (2024-2029)
